Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.
One of the most widely used drugs may be taken every day after a heart attack or stroke and to prevent first occurrences in some cases if benefits outweigh risks.
Cardiology drugs may cause harm in vulnerable populations, including the elderly, and reducing or discontinuing certain medications strives to avoid this negative outcome.
Ischemic heart disease remains the leading cause of cardiovascular disease (CVD) mortality worldwide, with an age-standardized rate per 100,000 of 108.8 deaths.